Immunology
Pipeline Moves: Pfizer’s flu vaccine approval chances rise after Phase III completion
This week on Pipeline Moves, we kick off by looking at a Phase III trial completion of Pfizer’s influenza vaccine…
Pfizer’s Velsipity UK approval raises competition in the ulcerative colitis market
The recent approval of Pfizer’s oral drug, Velsipity (etrasimod), by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for…
Allergy Therapeutics doses patients in second part of peanut allergy trial
UK-based Allergy Therapeutics has commenced dosing of the second part of a Phase I/IIa trial of its subcutaneous virus-like particle…
FDA lifts two-year clinical hold on CytoDyn’s HIV trial
The FDA has lifted the clinical hold on CytoDyn’s leronlimab, allowing the company to evaluate the therapy as a treatment…
Can artificial intelligence automate lupus nephritis diagnoses?
Systemic lupus erythematosus (SLE) is a systemic, inflammatory, chronic autoimmune disease that can affect multiple organs simultaneously or sequentially, with…
Could microRNAs offer a new approach to lupus nephritis diagnosis?
Over the recent years, research into systemic lupus erythematosus (SLE) has focused on understanding the needs of patients with lupus…
Travere signs $120m licencing deal with Renalys for sparsentan in Asia
Travere Therapeutics has signed a licencing agreement for sparsentan with Japan-based Renalys Pharma for multiple Asian countries. As per the…
Evommune begins Phase I trial of EVO756 for spontaneous urticaria
Evommune has commenced a Phase I first-in-human clinical trial of new oral treatment, EVO756, for chronic spontaneous urticaria (CSU). The…
Roche and Novartis’ Xolair set for FDA priority review in food allergies
Genentech (Roche) and Novartis’ Xolair (omalizumab) could soon become a treatment option for multiple food allergy reactions after the FDA…
The opportunities arising from the unmet needs in bronchiectasis
With the increasing prevalence rate of bronchiectasis over the years, patients, physicians, and pharmaceutical companies are seeking effective management and…
